J3 Bioscience Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $20K

  • Investors
  • 2

J3 Bioscience General Information

Description

Developer of a biomedical device designed to help improve female reproductive health. The company's device specializes in creating an intravaginal ring that is intended as a long-lasting vaginal lubricating moisturizer and provides a method to enhance the ease and comfort of sexual activity and supplement the body's natural lubrication that continuously delivers moisture and contains no hormones or drugs, enabling women to maintain vaginal health.

Contact Information

Website
www.j3bio.com
Formerly Known As
Viropan
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Corporate Office
  • Northgate Park, 825 North 300 West
  • Suite N231
  • Salt Lake City, UT 84103
  • United States
+1 (801) 000-0000

J3 Bioscience Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

J3 Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 27-Oct-2023 $20K 00.000 Completed Generating Revenue
8. Later Stage VC 07-Jun-2023 0000 00.000 Completed Generating Revenue
7. Later Stage VC (Series B) 01-Nov-2022 000 00.000 0000 Completed Generating Revenue
6. Later Stage VC (Series A3) 11-May-2021 00.000 00.000 000.00 Completed Generating Revenue
5. Later Stage VC (Series A2) 18-Dec-2019 00000 00.000 0000 Completed Generating Revenue
4. Later Stage VC (Series A1) 28-Aug-2017 00000 00.000 00.000 Completed Generating Revenue
3. Seed Round 23-Nov-2015 00.000 00.000 00.000 Completed Generating Revenue
2. Seed Round 29-Nov-2012 $700K $1M 00.00 Completed Generating Revenue
1. Angel (individual) 18-Jul-2007 $300K $300K 00000 Completed Generating Revenue
To view J3 Bioscience’s complete valuation and funding history, request access »

J3 Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-1 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Seed II 1,400,000 $0.010000 $0.6 $0.6 1x $0.6 9.88%
Seed I 4,400,000 $0.010000 $0.3 $0.3 1x $0.3 31.04%
To view J3 Bioscience’s complete cap table history, request access »

J3 Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biomedical device designed to help improve female reproductive health. The company's device specializes i
Therapeutic Devices
Salt Lake City, UT
5 As of 2022
00.000
0000000000 0 00.000

0000 0

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vo
00000000 00000000
Eugene, OR
00 As of 0000
0000
00000 0000-00-00
0000000 0000 0000

000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse c
000000000000000
Harrison, NY
00 As of 0000
0000
00000 0000-00-00
000000&0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

J3 Bioscience Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Good Clean Love Private Equity-Backed Eugene, OR 00 0000 0000000 0000 0000
Bonafide Health Formerly PE-Backed Harrison, NY 00 0000 000000&0 0000
NeuEve Corporation Arlington Heights, IL 0 0000000000
You’re viewing 3 of 3 competitors. Get the full list »

J3 Bioscience Executive Team (4)

Name Title Board Seat Contact Info
Duck Lee Ph.D Co-Chief Executive Officer, Green Cross Cell Clinical Development & Board Member
R. Tyler McCabe Ph.D Co-Founder, Co-Chief Executive Officer, President, Development Lead & Board Member
Jayne Carney Ph.D Executive of Market/Commercial, M&A, Licensing & Board Member
Tim Glassett JD General Counsel & Chairman
To view J3 Bioscience’s complete executive team members history, request access »

J3 Bioscience Board Members (8)

Name Representing Role Since
Duck Lee Ph.D J3 Bioscience Co-Chief Executive Officer, Green Cross Cell Clinical Development & Board Member 000 0000
Jayne Carney Ph.D J3 Bioscience Executive of Market/Commercial, M&A, Licensing & Board Member 000 0000
Ron Nielsen J3 Bioscience Board Member 000 0000
R. Tyler McCabe Ph.D J3 Bioscience Co-Founder, Co-Chief Executive Officer, President, Development Lead & Board Member 000 0000
Stath Karras J3 Bioscience Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

J3 Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

J3 Bioscience Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Salt Lake Life Science Angels Angel Group Minority 000 0000 000000 0
TCA Venture Group Angel Group Minority 000 0000 000000 0
To view J3 Bioscience’s complete investors history, request access »

J3 Bioscience FAQs

  • When was J3 Bioscience founded?

    J3 Bioscience was founded in 2007.

  • Who is the founder of J3 Bioscience?

    R. Tyler McCabe Ph.D is the founder of J3 Bioscience.

  • Who is the CEO of J3 Bioscience?

    Duck Lee Ph.D and R. Tyler McCabe Ph.D are the CEOs of J3 Bioscience.

  • Where is J3 Bioscience headquartered?

    J3 Bioscience is headquartered in Salt Lake City, UT.

  • What is the size of J3 Bioscience?

    J3 Bioscience has 5 total employees.

  • What industry is J3 Bioscience in?

    J3 Bioscience’s primary industry is Therapeutic Devices.

  • Is J3 Bioscience a private or public company?

    J3 Bioscience is a Private company.

  • What is J3 Bioscience’s current revenue?

    The current revenue for J3 Bioscience is 000000.

  • How much funding has J3 Bioscience raised over time?

    J3 Bioscience has raised $5.66M.

  • Who are J3 Bioscience’s investors?

    Salt Lake Life Science Angels and TCA Venture Group have invested in J3 Bioscience.

  • Who are J3 Bioscience’s competitors?

    Good Clean Love, Bonafide Health, and NeuEve are competitors of J3 Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »